JULIE WATERBURY: Open Payments
NPI 1447552260 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,865 in 15 payments from 5 companies in 2025. Trend: 2023 $42,365 · 2024 $3,980 · 2025 $1,865
Food & beverage: $1,125Consulting: $740
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $1,193 |
| Alkermes, Inc. | 6 | $310 |
| Luye Pharma (USA) Ltd. | 1 | $123 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $117 |
Products named: COBENFY, LYBALVI, ARISTADA, ERZOFRI EXTENDED-RELEASE, INGREZZA, UZEDY.
Industry payments across MO — which companies pay providers there.
